Cargando…

Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India

STUDY OBJECTIVES: Obesity is often considered mandatory for the diagnosis of Metabolic Syndrome (MS). Data on the prevalence of MS in non-obese patients with Obstructive Sleep Apnea (OSA) is scarce. This study was aimed to determine the prevalence of MS in non-obese patients with OSA. METHODOLOGY: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Poonam, Goyal, Abhishek, Pakhare, Abhijit, Goel, S. K., Kumar, Ashok, Reddy, Mallu Abhinav, Anoohya, Vangala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289879/
https://www.ncbi.nlm.nih.gov/pubmed/34283339
http://dx.doi.org/10.1007/s11325-021-02401-4
_version_ 1783724385334460416
author Chaudhary, Poonam
Goyal, Abhishek
Pakhare, Abhijit
Goel, S. K.
Kumar, Ashok
Reddy, Mallu Abhinav
Anoohya, Vangala
author_facet Chaudhary, Poonam
Goyal, Abhishek
Pakhare, Abhijit
Goel, S. K.
Kumar, Ashok
Reddy, Mallu Abhinav
Anoohya, Vangala
author_sort Chaudhary, Poonam
collection PubMed
description STUDY OBJECTIVES: Obesity is often considered mandatory for the diagnosis of Metabolic Syndrome (MS). Data on the prevalence of MS in non-obese patients with Obstructive Sleep Apnea (OSA) is scarce. This study was aimed to determine the prevalence of MS in non-obese patients with OSA. METHODOLOGY: All consecutively diagnosed patients with OSA between October 2018 and November 2019 were screened for metabolic syndrome. Patients with OSA and BMI < 25 kg/m(2) (NOOSA) vs BMI > 25 kg/m(2) (obese OSA) were compared. Lean waist NOOSA was defined as BMI < 25 kg/m(2) and WC < 80 cm (32 in.) for women or < 90 cm (36 in.) for men. RESULTS: During the study period, 502 patients were diagnosed with OSA. MS was observed in 35% of patients with NOOSA compared to obese patients with OSA (79%). In the NOOSA group, hypertension, impaired fasting glucose, diabetes mellitus and dyslipidemia were observed in 65, 48, 14 and 61% respectively and all of these parameters were significantly more common in the obese group (p < 0.001). Parameters of OSA severity (apnea-hypopnea index or AHI, time spent below 90% saturated or T90, and nadir oxygen) were significantly more severe in the obese group with OSA. Approximately 83% of patients in the NOOSA group had at least two metabolic risk factors, compared to the obese OSA group, in which 95% had two or more metabolic risk factors. Sixty-four percent of patients with NOOSA with lean waist had at least two metabolic risk factors. At BMI cut-offs of < 25, < 27 and < 30 kg/m2; 35, 46 and 57% of patients with OSA respectively had metabolic syndrome. CONCLUSION: Metabolic syndrome was observed in approximately one in three patients with OSA and BMI < 25 kg/m(2). Approximately two of every three lean waist non-obese patients with OSA had at least two markers of metabolic syndrome. The role of OSA in the development of metabolic syndrome in non-obese individuals needs further exploration.
format Online
Article
Text
id pubmed-8289879
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82898792021-07-20 Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India Chaudhary, Poonam Goyal, Abhishek Pakhare, Abhijit Goel, S. K. Kumar, Ashok Reddy, Mallu Abhinav Anoohya, Vangala Sleep Breath Sleep Breathing Physiology and Disorders • Original Article STUDY OBJECTIVES: Obesity is often considered mandatory for the diagnosis of Metabolic Syndrome (MS). Data on the prevalence of MS in non-obese patients with Obstructive Sleep Apnea (OSA) is scarce. This study was aimed to determine the prevalence of MS in non-obese patients with OSA. METHODOLOGY: All consecutively diagnosed patients with OSA between October 2018 and November 2019 were screened for metabolic syndrome. Patients with OSA and BMI < 25 kg/m(2) (NOOSA) vs BMI > 25 kg/m(2) (obese OSA) were compared. Lean waist NOOSA was defined as BMI < 25 kg/m(2) and WC < 80 cm (32 in.) for women or < 90 cm (36 in.) for men. RESULTS: During the study period, 502 patients were diagnosed with OSA. MS was observed in 35% of patients with NOOSA compared to obese patients with OSA (79%). In the NOOSA group, hypertension, impaired fasting glucose, diabetes mellitus and dyslipidemia were observed in 65, 48, 14 and 61% respectively and all of these parameters were significantly more common in the obese group (p < 0.001). Parameters of OSA severity (apnea-hypopnea index or AHI, time spent below 90% saturated or T90, and nadir oxygen) were significantly more severe in the obese group with OSA. Approximately 83% of patients in the NOOSA group had at least two metabolic risk factors, compared to the obese OSA group, in which 95% had two or more metabolic risk factors. Sixty-four percent of patients with NOOSA with lean waist had at least two metabolic risk factors. At BMI cut-offs of < 25, < 27 and < 30 kg/m2; 35, 46 and 57% of patients with OSA respectively had metabolic syndrome. CONCLUSION: Metabolic syndrome was observed in approximately one in three patients with OSA and BMI < 25 kg/m(2). Approximately two of every three lean waist non-obese patients with OSA had at least two markers of metabolic syndrome. The role of OSA in the development of metabolic syndrome in non-obese individuals needs further exploration. Springer International Publishing 2021-07-20 2022 /pmc/articles/PMC8289879/ /pubmed/34283339 http://dx.doi.org/10.1007/s11325-021-02401-4 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Sleep Breathing Physiology and Disorders • Original Article
Chaudhary, Poonam
Goyal, Abhishek
Pakhare, Abhijit
Goel, S. K.
Kumar, Ashok
Reddy, Mallu Abhinav
Anoohya, Vangala
Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title_full Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title_fullStr Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title_full_unstemmed Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title_short Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India
title_sort metabolic syndrome in non-obese patients with osa: learning points of a cross-sectional study from a tertiary care hospital in central india
topic Sleep Breathing Physiology and Disorders • Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289879/
https://www.ncbi.nlm.nih.gov/pubmed/34283339
http://dx.doi.org/10.1007/s11325-021-02401-4
work_keys_str_mv AT chaudharypoonam metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT goyalabhishek metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT pakhareabhijit metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT goelsk metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT kumarashok metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT reddymalluabhinav metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia
AT anoohyavangala metabolicsyndromeinnonobesepatientswithosalearningpointsofacrosssectionalstudyfromatertiarycarehospitalincentralindia